Belzutifan
PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC) . PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
383.34
Molecular Formula
C17H12F3NO4S
Notes
Research use only, not for human use.
Receptor
——
CAS Number
1672668-24-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7077873 Inquire
Recombinant Shigella boydii serotype 4 Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA), partial
Ask
View Details 